For example, a head-to-head trial (SURMOUNT-5) reported 20.2% weight loss with tirzepatide vs 13.7% with semaglutide 2.4 mg over ~72 week
,
If you are evaluating Empower, weigh the reviews against your own risk tolerance
Eli Lilly did not respond to the question
Release and Function of GLP-1 GLP-1 is a hormone, or chemical messenger, that gets released during digestion
Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically starting at 2.5 mg for 4 weeks, then increasing by 2.5 mg every 4 weeks as tolerated (through intermediate steps of 5 mg, 7.5 mg, 10 mg, 12.5 mg) to a maintenance dose of 5 mg, 10 mg, or 15 mg based on individual response and tolerability